CURRENT Med Diag & Treatment
64
Quality Score
Solid
✍️ Bumetric analysis
“
CURRENT Med Diag & Treatment is an iOS app from Skyscape Medpresso Inc in the Education category, currently rated 4.4★ across 114 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 64: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
→
12-mo forecast
$5.2K – $10.8K
per month
→
24-mo forecast
$6.4K – $19.2K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
17 snapshots on record
Rating
4.4
Reviews
114 reviews
Forecast Revenue / mo
$5.0K
Snapshots tracked
17
since Jan 2020
🤖Also on Android
$327/mo · 1K ratings · 4.1★
View →
ONE-TIME · BUILD
💰 Estimated build cost
$115K
↳ What it cost to build · not monthly revenue
Likely range $85K – $155K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~1.9y at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
| ⚙ 8.9y maintenance × ~1-person team | +$53K |
Total estimate
$115K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$100K
↳ What it would sell for · not monthly revenue
Marketplace range $75K – $125K · 18× MRR multiple
💸
~0.9× build cost (under-water)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 📅 8.9y proven track record | +20% |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
18× MRR
👥 Estimated audience size
6.7K
Lifetime downloads (US-equivalent)
Monthly active
710
Daily active
210
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Education engagement | ~85 installs / rating |
| 📅 8.9y of rating accumulation | -30% |
| 🔁 Education D30 retention | 18% |
| 📍 DAU / MAU stickiness | 0.30 |
DAU / MAU
30% sticky
🛠 Estimated tech stack
🍎
Native iOS (Swift / UIKit)
Medium confidence · 70%
Also possible
Flutter
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
Signals we read
| 📦 App bundle size | 46 MB |
| 🏷 Category context | Education |
| 📦 Small-mid iOS bundle | → Native Swift / UIKit (pre-2020 era) |
💀 Maintenance status
Slowing
25%
Last shipped 2026-08-26 · 74 days ago
0 · Active
50 · At risk
100 · Abandoned
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
Risk signals
| 📅 74 days since last update | Healthy release cadence |
| 👥 Small user base (114 ratings) + 8.9y old | +10% (solo-project pattern) |
Verdict
Slowing
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 53/100MID TIERunderperforming peersGrowth Velocity
5.0
Founder Strength
7.5
Product Quality
6.1
Revenue Strength
3.7
Monetization Maturity
1.0
Defensibility
7.2
Market Position
2.0
Operational Safety
10.0
- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.39★ across 114 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K. Portfolio play ($90K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 7 of 7 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| subscriptionREVIEW | +$2,500 | |
| Mature app (8y old)METRIC | +$1,500 | |
| free trialREVIEW | +$1,200 | |
| Good rating (4.4★)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Early-stage install base (114 ratings)METRIC | +$400 | |
| Single-language (English only)METRIC | −$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v5.10.0
* Improved app stability and resolved crash issues for a smoother experience.
* Added a Force Update feature to ensure you have access to the latest app version and improvements.
* Enhanced app performance and reliability.
* General bug fixes and improvements.
* Added a Force Update feature to ensure you have access to the latest app version and improvements.
* Enhanced app performance and reliability.
* General bug fixes and improvements.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- CURRENT Med Diag & Treatment
- Developer
- Skyscape Medpresso Inc
- Bundle ID
- com.medpresso.Lonestar.cmdt
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $5.0K/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth114 ratings+11300% lifetimeShow 3-year history estimate ▾
Tracked (17 weeks) Pre-tracking estimate (0 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
🚀Update Frequency · Releases per Quarter2 releases tracked
🚀Version Release Timeline2 releases tracked
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content.
The #1 annual guide in adult internal medicine.
Each year CURRENT Medical Diagnosis and Treatment (CMDT) undergoes extensive revision to deliver new clinical developments in every field of adult internal medicine—making it the most popular annual textbook of its kind.
For more than six decades, CMDT has been disseminating authoritative information that students, residents, and clinicians need to build their medical knowledge, expertise, and confidence.… View full description on the official store →
The #1 annual guide in adult internal medicine.
Each year CURRENT Medical Diagnosis and Treatment (CMDT) undergoes extensive revision to deliver new clinical developments in every field of adult internal medicine—making it the most popular annual textbook of its kind.
For more than six decades, CMDT has been disseminating authoritative information that students, residents, and clinicians need to build their medical knowledge, expertise, and confidence.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 46 MB🔞 17+📱 iOS 13.0+🔖 v5.10.0🔄 updated 2mo ago🌐 EN📂 Education💰 Paid🚀 Launched 2017 (8y old)
📅
What Worked™ · Development Pipeline
10 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-08
🔧
Shipped update — v5.8.5 → v5.10.0
2026-08
📦
Bundle ↓ 151MB → 48MB — likely major code refresh
2026-05
🔄
Monetization changed: paid → free
2026-03
⭐
Rating ↑ 1.80 → 4.41 (improved 2.61★)
2026-03
📈
Crossed 50 ratings — social-proof flywheel kicking in
2026-02
📈
Crossed 10 ratings — social-proof flywheel kicking in
→ 30 days after: revenue +$132/mo · rating +2.61★ · reviews +101 high confidence
2026-02
⭐
Rating ↑ 1.44 → 1.80 (improved 0.36★)
→ 30 days after: revenue +$132/mo · rating +2.61★ · reviews +101 high confidence
2022-11
⭐
Rating ↓ 2.33 → 2.00 (dropped 0.33★)
2022-02
⭐
Rating ↑ 1.00 → 2.33 (improved 1.33★)
2020-01
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 4.66667★ | 3 | 4.66667★ this version |
| 🇧🇷 BR | 4.77778★ | 9 | 4.77778★ this version |
| 🇨🇦 CA | 5★ | 7 | 5★ this version |
| 🇩🇪 DE | 4★ | 2 | 4★ this version |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇬🇧 GB | 4.5★ | 2 | 4.5★ this version |
| 🇮🇳 IN | 4.22222★ | 18 | 4.22222★ this version |
| 🇯🇵 JP | 4.33333★ | 3 | 4.33333★ this version |
| 🇺🇸 US | 4.3913★ | 115 | 4.3913★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for CURRENT Med Diag & Treatment: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
More by Skyscape Medpresso Inc
View all →📦 Portfolio summaryBIG studio
203apps·$1.4M/mocombined
Lead-app heavy — top app contributes 51%
About this analysis
Why medium confidence: 114 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
10 answers · auto-generated from this app's public dataHow much does CURRENT Med Diag & Treatment make per month?▴
Based on our ML-calibrated revenue forecast, CURRENT Med Diag & Treatment earns approximately $5.0K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
Is CURRENT Med Diag & Treatment profitable?▴
With estimated build cost $115K and monthly revenue $5.0K, CURRENT Med Diag & Treatment looks break-even-grade — payback period sits around 1.9 years. Profitability also depends on paid-acquisition spend and refund rate which the public model doesn't see.
How many users does CURRENT Med Diag & Treatment have?▴
Estimated audience: ~6K lifetime downloads, ~710 monthly active users, and ~210 daily active users. Derived from ratings count × category installs-per-rating × age decay. US-storefront-equivalent — global audience can be 5-10× larger for internationally-distributed apps.
What apps are like CURRENT Med Diag & Treatment?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is CURRENT Med Diag & Treatment built with?▴
Our heuristic places CURRENT Med Diag & Treatment on the Native iOS (Swift / UIKit) stack (Medium confidence, 70%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Flutter.
Is CURRENT Med Diag & Treatment still actively maintained?▴
Maintenance status: Slowing (25% abandonment risk). Last shipped version was 2 months ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
How much would CURRENT Med Diag & Treatment sell for?▴
Estimated acquisition value: $100K (marketplace range $75K – $125K). Calculated as 18× monthly revenue using the standard multiple for the detected monetization model + adjustments for age, rating quality and category demand. Calibrated against 2024-2026 Flippa / Acquire.com / MicroAcquire closed-deal medians.
When was CURRENT Med Diag & Treatment last updated?▴
CURRENT Med Diag & Treatment last shipped a new version on 2026-08-26 — 2 months ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes CURRENT Med Diag & Treatment?▴
CURRENT Med Diag & Treatment is published by Skyscape Medpresso Inc on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is CURRENT Med Diag & Treatment's BU Score?▴
CURRENT Med Diag & Treatment has a BU Score of 64/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.